Pfiz­er could end Lip­i­tor an­titrust saga in­volv­ing Ran­baxy with $93M set­tle­ment

Pfiz­er has of­fered $93 mil­lion to set­tle an an­titrust law­suit brought by drug dis­trib­u­tors al­leg­ing it worked with In­dia’s Ran­baxy Lab­o­ra­to­ries to de­lay sales of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER